Mosaicism in Short Tandem Repeat Disorders: A Clinical Perspective

Area of Science:

• Genetics
• Molecular Biology
• Epigenetics

Background:

• Human disorders such as Fragile X syndrome, Huntington disease, and myotonic dystrophy type 1 are characterized by short tandem repeat (STR) variations.
• STRs are repetitive DNA sequences prone to mutation in both germline and somatic cells, leading to instability like expansion and contraction.
• This instability results in somatic mosaicism, where genetic and epigenetic states vary across cells within an individual.

Purpose of the Study:

• To review the emerging understanding of somatic mosaicism in the pathogenesis of STR repeat expansion disorders.
• To highlight the critical role of mosaicism in cellular physiology and clinical phenotypes of these diseases.
• To focus on Fragile X, Huntington disease, and myotonic dystrophy type 1 as key examples.

Main Methods:

• Review of existing literature on short tandem repeat disorders.
• Analysis of recent technological advancements and bioinformatic approaches.
• Focus on studies investigating somatic mosaicism in Fragile X, Huntington disease, and myotonic dystrophy type 1.

Main Results:

• Somatic mosaicism is a significant factor in the pathogenesis of STR repeat expansion disorders.
• Cell-to-cell variation in genotype and epigenetic state at STR loci contributes to disease phenotypes.
• New technologies are enabling a clearer focus on the role of mosaicism.

Conclusions:

• Somatic mosaicism plays a critical role in the clinical presentation of disorders like Fragile X, Huntington disease, and myotonic dystrophy type 1.
• Further research into mosaicism is essential for understanding and potentially treating these STR repeat disorders.
• The interplay between genetic instability, epigenetic changes, and cellular heterogeneity drives disease pathology.